In particular, the loss of function of breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) is a predisposing factor for developing not only ovarian, pancreatic and breast cancers, but also prostate cancer. This evidence concerns the gene BRCA2 and prostate cancer.